The mission of GAFIO is to advance technological development and clinical translation of AI in oncology, support international, multidisciplinary collaborative AI research in oncology, and promote excellence in cancer care through education, research, and innovation in the emerging field of intelligent oncology. We specifically focus on key areas including education, research, clinical practice, global collaboration, and advocacy, aiming to achieve excellence in cancer care.
GAFIO is committed to providing high-quality educational resources on AI in oncology to professionals through conferences, workshops, online courses, and published materials to facilitate continuous learning and professional development.
GAFIO promotes interdisciplinary research in intelligent oncology, which integrates clinical oncology, radiology, pathology, molecular biology, and AI. By funding research projects, fostering global collaboration, and sharing findings, GAFIO advances scientific knowledge and technological innovations in intelligent oncology.
GAFIO strives to improve clinical practice by advocating for safe, effective use of AI in oncology, promoting evidence-based practices, guidelines, and standards to ensure the high-quality of cancer screening, diagnosis, and treatment.
GAFIO fosters global collaboration and knowledge exchange in intelligent oncology, through outreach programs, collaborations with medical institutions, and participation in cancer initiatives and clinical trials, to address clinical and technological challenges in applying AI to clinical oncology.
GAFIO advocates for policies and initiatives that support AI in clinical oncology by promoting fair reimbursement policies, addressing regulatory considerations, and emphasizing the role of AI in cancer care decision-making across prevention, screening, diagnosis, treatment, and prognosis.